Kbp Biosciences Stock

kbpbiosciences.comBioTechFounded: 2007Funding to Date: $76MM

KBP is a biotechnology company focused on organ, antimicrobial, and immunology research.

Register for Details

For more details on financing and valuation for Kbp Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Fred Yang Ph.D
Chief Development Officer
Vince Benn Ph.D
Vice President, Regulatory & Medical Affairs
Robert Segal MD
Deputy Chief Medical Officer

Board Members

Benjamin Qiu
Bing Wang Ph.D
Frederick Craves Ph.D
Bay City Capital
Huang Zhenhua Ph.D

Other companies like Kbp Biosciences in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

Clinical-stage biotechnology firm KBP Biosciences has secured a $76 million Series A financing round led by Advantech Capital and SDIC Venture Capital.
KBP Biosciences, a Greater Philadelphia Area and Jinan, China-based private clinical-stage biotechnology company dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need, closed a $76m Series A financing. The round was co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay …